Plexxikon | Evaluate

No respite for private biotech takeovers

If you thought Aragon’s exit was impressive, check out Seragon

May 21, 2014

Asco preview – Failed brain cancer project gets a second shot

July 16, 2013

Early-stage asset risk no deterent to partnering deals

February 07, 2013

M&A activity cools in 2012 as break-ups loom

November 24, 2011

History not on Gilead's side in high stakes gamble on Pharmasset

August 23, 2011

Encouraging 2011 M&A trends seen but big pharma inactivity concerning

March 03, 2011

Event - BMS readies for two big ipi events

March 01, 2011

Daiichi pays handsome price for Plexxikon

September 10, 2010

Therapeutic focus - Melanoma awaiting breakthrough but data approaching

February 25, 2010

Resurgence of conventional and untrendy therapy area product deals in 2009

Load More